BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Okumura K, Mekata E, Shiomi H, Naitoh H, Abe H, Endo Y, Kurumi Y, Tani T. Expression level of thymidylate synthase mRNA reflects 5-fluorouracil sensitivity with low dose and long duration in primary colorectal cancer. Cancer Chemother Pharmacol 2008;61:587-94. [DOI: 10.1007/s00280-007-0511-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Stravopodis DJ, Karkoulis PK, Konstantakou EG, Melachroinou S, Thanasopoulou A, Aravantinos G, Margaritis LH, Anastasiadou E, Voutsinas GE. Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells. J Cancer Res Clin Oncol 2011;137:359-74. [PMID: 20425122 DOI: 10.1007/s00432-010-0891-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
2 Hwang HY. A practical approach for assessing chemosensitivity in colorectal cancer cell lines by comparative analysis of cell viability and thymidylate synthase mRNA expression. J Korean Surg Soc 2012;82:28-34. [PMID: 22324043 DOI: 10.4174/jkss.2012.82.1.28] [Reference Citation Analysis]
3 Sheikh R, Walsh N, Clynes M, O’Connor R, McDermott R. Challenges of drug resistance in the management of pancreatic cancer. Expert Rev Anticancer Ther. 2010;10:1647-1661. [PMID: 20942635 DOI: 10.1586/era.10.148] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
4 Bellot GL, Tan WH, Tay LL, Koh D, Wang X. Reliability of tumor primary cultures as a model for drug response prediction: expression profiles comparison of tissues versus primary cultures from colorectal cancer patients. J Cancer Res Clin Oncol 2012;138:463-82. [DOI: 10.1007/s00432-011-1115-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
5 Liu KP, Luo F, Xie SM, Tang LJ, Chen MX, Wu XF, Zhong XY, Zhao T. Glycogen Synthase Kinase 3β Inhibitor (2'Z,3'E)-6-Bromo-indirubin- 3'-Oxime Enhances Drug Resistance to 5-Fluorouracil Chemotherapy in Colon Cancer Cells. Chin J Cancer Res 2012;24:116-23. [PMID: 23359767 DOI: 10.1007/s11670-012-0116-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
6 Kucerova L, Feketeova L, Kozovska Z, Poturnajova M, Matuskova M, Nencka R, Babal P. In vivo 5FU-exposed human medullary thyroid carcinoma cells contain a chemoresistant CD133+ tumor-initiating cell subset. Thyroid 2014;24:520-32. [PMID: 24073856 DOI: 10.1089/thy.2013.0277] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Takebayashi K, Mekata E, Sonoda H, Shimizu T, Shiomi H, Naka S, Endo Y, Tani T. Differences in chemosensitivity between primary and metastatic tumors in colorectal cancer. PLoS One 2013;8:e73215. [PMID: 24015297 DOI: 10.1371/journal.pone.0073215] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
8 Chen Y, Yi C, Liu L, Li B, Wang Y, Wang X. Thymidylate synthase expression and prognosis in colorectal cancer: a meta-analysis of colorectal cancer survival data. Int J Biol Markers. 2012;27:e203-e211. [PMID: 23015402 DOI: 10.5301/jbm.2012.9584] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]